A cobalt-doped iron oxide nanozyme as a highly active peroxidase for renal tumor catalytic therapy

Yixuan Wang,Hongjun Li,Lihua Guo,Qi Jiang,Feng Liu

DOI: https://doi.org/10.1039/C8RA05487H

IF: 4.036

2019-10-07

RSC Advances

Abstract:The Fe 3 O 4 nanozyme, the first reported nanozyme with intrinsic peroxidase-like activity, has been successfully employed for various diagnostic applications. However, only a few studies have been reported on the therapeutic applications of the Fe 3 O 4 nanozyme partly due to its low affinity to the substrate H 2 O 2 . Herein, we report a new strategy for improving the peroxidase-like activity and affinity of the Fe 3 O 4 nanozyme to H 2 O 2 to generate reactive oxygen species (ROS) for kidney tumor catalytic therapy. We showed that cobalt-doped Fe 3 O 4 (Co@Fe 3 O 4 ) nanozymes possessed stronger peroxidase activity and a 100-fold higher affinity to H 2 O 2 than the Fe 3 O 4 nanozymes. The lysosome localization properties of Co@Fe 3 O 4 enable Co@Fe 3 O 4 to catalyze the decomposition of H 2 O 2 at ultralow doses for the generation of ROS bursts to effectively kill human renal tumor cells both in vitro and in vivo . Moreover, our study provides the first evidence that the Co@Fe 3 O 4 nanozyme is a powerful nanozyme for the generation of ROS bursts upon the addition of H 2 O 2 at ultralow doses, presenting a potential novel avenue for tumor nanozyme catalytic therapy.

chemistry, multidisciplinary